Register for our S/EIS Fund

We are back on the virtual couch with Jennifer Petter, one of the most successful Boston based scientific entrepreneurs who is a key part of the management team that sold Avila to Celgene (now part of BMS) for $565M.

Jennifer was joined by Ros Deegan a British born and trained, Ros has spent a significant amount of her time in the USA most recently she established and led UK-based Bicycle Therapeutics US subsidiary, supporting the series B fund raise and negotiating significant transactions with AstraZeneca ($1B+ potential).

The panelists
Jennifer Petter Founder at Arrakis Therapeutics

Jennifer Petter who is one of the most successful Boston based scientific entrepreneurs having been a key part of the management team that sold Avila to Celgene (now part of BMS) for $565M.

Rosamond Deegan CEO at Omass Therapeutics

Ros Deegan a British born and trained, Ros has spent a significant amount of her time in the USA most recently she established and led UK-based Bicycle Therapeutics US subsidiary, supporting the series B fund raise and negotiating significant transactions with AstraZeneca ($1B+ potential).

Sunil Shah CEO at o2h Ventures
(moderator)

Sunil Shah is a serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector.

Register for Invitations